Filter
432
Text search:
HIV
coinfection
Featured
Recommendations
46
New Publications
121
Language
Document type
No document type
307
Studies & Reports
44
Guidelines
43
Situation Updates
11
Fact sheets
7
Strategic & Response Plan
6
Manuals
5
Training Material
5
Infographics
2
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
18
Eastern Europe
17
Nepal
16
India
15
Latin America and the Carribbean
14
Asia
10
Rwanda
8
Namibia
8
South–East Asia Region
8
Global
8
Kenya
7
Tanzania
7
Ukraine
7
Myanmar / Burma
7
Congo, Democratic Republic of
6
Malawi
6
Russia
6
Nigeria
5
Ethiopia
5
Philippines
5
Zambia
5
Cambodia
5
South Africa
5
Sierra Leone
4
Ghana
4
Bangladesh
4
Argentina
3
Africa
3
Liberia
2
Senegal
2
Uganda
2
Zimbabwe
2
Mozambique
2
Benin
2
Peru
2
Brazil
2
Madagascar
2
Eastern Europe and Central Asia
2
Albania
2
Armenia
2
Tajikistan
2
Georgia
2
Haiti
1
Pakistan
1
Germany
1
Thailand
1
Indonesia
1
Central African Republic
1
Eswatini/ Swaziland
1
Colombia
1
Ecuador
1
East and Southern Africa
1
Paraguay
1
Laos
1
Estonia
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
North America
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
154
Clinical Guidelines
60
Public Health
6
Pharmacy & Technologies
5
Women & Child Health
4
Key Resources
4
Capacity Building
3
Toolboxes
TB
129
HIV
124
NTDs
17
Refugee
8
COVID-19
7
AMR
3
Caregiver
3
Ebola
2
Rapid Response
2
Mental Health
2
Global Health Education
2
Pharmacy
2
Polio
1
Conflict
1
Zika
1
Planetary Health
1
Health Financing Toolbox
1
Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su
...
Integrated Management of pregnancy and childbirth
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической практики
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Report of a mission 20–24 April 2015
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro
...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu
...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev
...
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл
...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
